Personalizing treatment for predicting response to infliximab in children with Crohn's disease using proteomic biomarkers
H. Winter,R. N. Baldassano,M. D. Pfeffkorn,P. Wali,S. G. Verstraete,J. A. Picoraro,M. A. Washek,N. Kumar,W. Mortan,M. Havard-,L. Blystone,B. Trombler,C. Pursley,X. Lin,S. T. Dillon,X. Gu,H. H. Otu,L. Ngo,T. A. Libermann
